Mind Medicine, Inc.

Rob Barrow’s path to becoming CEO of MindMed, a biotechnology company pioneering psychedelic medicine, follows what he describes as a “winding route.” Unlike many biotech executives who rise through t

For all its foibles, the human brain is the most complex object in the known universe. It contains 86 billion neurons, which together form 100 trillion connections – a supersystem that underpins every

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

Actuate Therapeutics, Inc. grossed $22.4m from its initial public offering of 2.8 million shares priced at $8 each in the 15th biopharmaceutical company IPO in the US in 2024. It was not the smallest